✦ LIBER ✦

Dasatinib Resistance in Patients with Chronic Myelogenous Leukemia: Identification of a Novel bcr-abl Kinase Domain Mutation

✍ Scribed by Krijanovski, Yelena; Donato, Nicholas; Sun, Hanshi; Meng, Feng; Quintás-Cardama, Alfonso; Cortés, Jorge E.; Talpaz, Moshe

Book ID: 121942390
Publisher: CIG Media Group, LP.
Year: 2008
Tongue: English
Weight: 105 KB
Volume: 2
Category: Article
ISSN: 1931-6925
DOI: 10.3816/CLK.2008.n.037

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Characteristics of BCR–ABL kinase domain

Characteristics of BCR–ABL kinase domain point mutations in Chinese imatinib-resistant chronic myeloid leukemia patients

✍ YaZhen Qin; ShanShan Chen; Bin Jiang; Qian Jiang; Hao Jiang; JinLan Li; LingDi L 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 116 KB

Chronic myeloid leukemia patients with F

Chronic myeloid leukemia patients with F317L BCR-ABL kinase domain mutation are resistant to dasatinib: Is that true for all the patients?

✍ Ahmet Emre Eskazan; Teoman Soysal; Yucel Erbilgin; Ugur Ozbek; Burhan Ferhanoglu 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 172 KB

BCR-ABL1 Kinase Domain Mutation Analysis

BCR-ABL1 Kinase Domain Mutation Analysis in an Irish Cohort of Chronic Myeloid Leukemia Patients

✍ McCarron, Sarah L.; O'Connor, Lisa M.; Langabeer, Stephen E.; Conneally, Eibhlin 📂 Article 📅 2013 🏛 Mary Ann Liebert 🌐 English ⚖ 96 KB

Imatinib resistance in a novel transloca

Imatinib resistance in a novel translocation der(17)t(1;17)(q25;p13) with loss of TP53 but without BCR/ABL kinase domain mutation in chronic myelogenous leukemia

✍ Katsuya Yamamoto; Kimikazu Yakushijin; Shinichiro Nishikawa; Kentaro Minagawa; Y 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 733 KB

O37 BCR-ABL kinase domain mutations and

O37 BCR-ABL kinase domain mutations and clonal evolution as major causes of resistance to targeted therapy in chronic myelogenous leukemia

✍ H. Andrikovics; N. Meggyesi; S. Lueff; A. Batai; E. Adam; A. Kozma; G. Halm; S. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 59 KB

Hb-Hana family is the first described example, where partial glutathione reductase deficiency represents a modifying factor of clinical manifestation of unstable hemoglobinopathy. Grant support: MSM 6198959205 and MSM 6198959216. O35 A prognostic impact of transfusion dependency on survival of pati

[Methods in Molecular Biology] Hematolog

[Methods in Molecular Biology] Hematological Malignancies Volume 999 || Detection of BCR-ABL1 Kinase Domain Mutations Causing Imatinib Resistance in Chronic Myelogenous Leukemia

✍ Czader, Magdalena 📂 Article 📅 2013 🏛 Humana Press ⚖ 367 KB